Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Total revenue	$ 419	$ 1,163	$ 2,498	$ 2,430
Expenses:
Cost of product revenues	41	56	139	158
Research and development	8,558	5,899	25,311	14,402
Selling, general and administrative	6,344	5,275	16,073	10,699
Total expenses	14,943	11,230	41,523	25,259
Loss from operations	(14,524)	(10,067)	(39,025)	(22,829)
Other income (expense):
Interest income (expense), net	915	63	2,741	(419)
Gain (loss) on fair value adjustment of warrant liability		36	(294)	(1,124)
Loss on debt extinguishment				(682)
Gain (loss) on fair value of strategic investments	293	(314)	276	1,196
Total other income (expense)	1,208	(215)	2,723	(1,029)
Net loss	$ (13,316)	$ (10,282)	$ (36,302)	$ (23,858)
Net loss per share
Basic (in Dollars per share)	$ (0.38)	$ (0.51)	$ (1.11)	$ (1.80)
Diluted (in Dollars per share)	$ (0.38)	$ (0.51)	$ (1.11)	$ (1.80)
Weighted-average shares used in computing net loss per share, basic (in Shares)	35,243,598	20,187,773	32,586,431	13,236,450
Weighted-average shares used in computing net loss per share, diluted (in Shares)	35,243,598	20,187,773	32,586,431	13,236,450
Comprehensive loss
Net loss	$ (13,316)	$ (10,282)	$ (36,302)	$ (23,858)
Unrealized loss on marketable securities	19		(69)
Comprehensive loss	(13,297)	(10,282)	(36,371)	(23,858)
Partnership revenue
Revenue:
Total revenue	271	986	2,018	1,931
Product revenue
Revenue:
Total revenue	$ 148	$ 177	$ 480	$ 499